Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Vanguard

Vanguard Health Care Fund Investor Shares (VGHCX)

Ticker VGHCX · · Holdings as of Jul 31, 2026

Expense ratio
0.33%$33/yr per $10k
5-yr return
+6.6%annualized
1-yr return
+17.3%as of Dec 2025
Net assets
$38.2Ball share classes
Holdings
97

Bottom line

Is VGHCX a good fund? The bottom line

VGHCX is the Investor share class of Vanguard Health Care Fund, a managed health care sector mutual fund from Vanguard.

It charges 0.33% — about $33 a year on every $10,000 invested, cheaper than 93% of health care sector funds we track.

It returned +17.3% over one year, +6.6% a year over five years, +7.7% a year over ten (as of Dec 31, 2025, per its prospectus).

With $38.2 billion in net assets and 97 holdings, its largest position is Eli Lilly & Co (8.6%) and the top 10 make up 40.6% of the portfolio.

The closest lower-cost alternative we found is XLV (0.08%, 53% top-holdings overlap).

What stands out

  • Low cost: cheaper than 93% of health care sector peers
  • 5-year return beat 79% of category peers
  • No front-end sales load
  • Large and established ($38.2 billion)

Updated Nov 19, 2026

What VGHCX invests in

Vanguard Health Care Fund (the Fund) seeks to provide long-term capital appreciation.

The Fund employs an active management approach. Under normal circumstances, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the stocks of companies principally engaged in the development, production, or distribution of products and services related to the health care industry. For purposes of the 80% policy, these companies include, among others, pharmaceutical firms, medical supply companies, and businesses that operate hospitals and other health care facilities, and the Fund may also consider companies engaged in medical, diagnostic, biochemical, and other research and development activities. The Funds advisor strives for a balanced representation of the health care field, searching for the best values in the various subsectors of the industry. The Fund may invest up to 50% of its assets in foreign stocks. The Fund is…

From the fund's prospectus (filed May 28, 2026).

VGHCX performance

Fund calendar-year total returns, 2018–2025 2018: +1.2%; 2019: +22.9%; 2020: +12.6%; 2021: +14.3%; 2022: −1.1%; 2023: +5.4%; 2024: −1.6%; 2025: +17.3% +1% 2018 +23% 2019 +13% 2020 +14% 2021 −1% 2022 +5% 2023 −2% 2024 +17% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
VGHCX+17.3%+6.6%+7.7%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2025

Full VGHCX performance history →

What VGHCX costs

On a $10,000 investment, VGHCX's 0.33% expense ratio costs about $33 a year. The prospectus estimates $418 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full VGHCX fee table →

VGHCX top 10 holdings

#Holding% of fund
1Eli Lilly & Co8.61%
2Merck & Co Inc5.44%
3Johnson & Johnson4.83%
4AstraZeneca PLC4.59%
5UnitedHealth Group Inc4.05%
6Gsk Plc3.00%
7Edwards Lifesciences Corp2.56%
8Intuitive Surgical Inc2.52%
9CVS Health Corp2.52%
10Cencora Inc2.47%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 40.6% of the fund. See all top 25 holdings and asset mix →

Alternatives to VGHCX

Closest equivalent at other fund companies
FamilyFundExpense ratioOverlap
SPDR (State Street)XLV State Street(R) Health Care Select…0.08%53% Compare
FidelityFHLC Fidelity MSCI Health Care Index ETF0.084%53% Compare
iSharesIXJ iShares Global Healthcare ETF0.38%55% Compare
J.P. MorganJDOC JPMorgan Healthcare Leaders ETF0.65%62% Compare

More funds like VGHCX →

VGHCX FAQ

What is the expense ratio of VGHCX?
VGHCX's expense ratio is 0.33%, which works out to about $33 a year for every $10,000 invested. The prospectus estimates total costs of $418 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is VGHCX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 93% of health care sector peers; 5-year return beat 79% of category peers; no front-end sales load; large and established ($38.2 billion). This is general information, not personalized advice.
What does VGHCX hold?
VGHCX's largest holdings are Eli Lilly & Co (8.6%), Merck & Co Inc (5.4%), Johnson & Johnson (4.8%), AstraZeneca PLC (4.6%), UnitedHealth Group Inc (4.0%). It holds 97 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is VGHCX's 5-year return?
VGHCX returned +6.6% a year over the five years ending Dec 31, 2025, and +7.7% a year over ten years. Past performance does not guarantee future results.
Does VGHCX have a sales load?
No. VGHCX has no front-end sales charge.
What is a cheaper alternative to VGHCX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) overlaps about 53% with VGHCX and charges 0.08%.
Who manages VGHCX?
VGHCX is offered by Vanguard through Vanguard Specialized Funds.